Medtronic plc, an Ireland-based global healthcare technology company with a market capitalization of approximately $105.4 billion, develops and manufactures medical devices, software, and AI-powered solutions addressing more than 70 medical conditions. The company’s product portfolio spans cardiovascular, neuroscience, diabetes, surgical, and other therapeutic areas.
The company was scheduled to report first-quarter fiscal year 2027 earnings before market open on September 1, 2026. Analys